Sage Therapeutics Inc

NASDAQ:SAGE   4:00:00 PM EDT
18.74
-0.30 (-1.58%)
4:04:22 PM EDT: $18.74 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.13B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$5.22 Million
Adjusted EPS-$1.63
See more estimates
10-Day MA$19.33
50-Day MA$22.73
200-Day MA$25.77
See more pivots

Sage Therapeutics Inc Stock, NASDAQ:SAGE

215 1st Street, Cambridge, Massachusetts 02142
United States of America
Phone: +1.617.299.8380
Number of Employees: 487

Description

SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain. Its products include ZURZUVAE and ZULRESSO. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010 and is headquartered in Cambridge, MA.